Latest News

Latest News and Events

  • All
  • Events
  • Featured
  • Imspex Clinical
  • Imspex Industrial
Featured

Imspex & Biophys Partner to Drive SMART Diagnostics at New South Wales Lab

We are pleased to announce a significant collaboration between Imspex Diagnostics Ltd and Biophys Limited, aimed at advancing SMART diagnostics and R&D services. This partnership ...
Read More →
Featured

David Wilson Joins Imspex as Non-Executive Director

Imspex Diagnostics is pleased to announce the appointment of David Wilson to our board of directors as a Non-Executive Director. David brings over 30 years ...
Read More →
Featured

IMSPEX NEWS

PRESS RELEASE Imspex Announces Sale of Its German Subsidiary, Paving the Way for Standalone UK Entity Dedicated to Advancing Clinical Diagnostics and Leading in Breathomics. ...
Read More →
Featured

Meet Robin Curnow

📢IMSPEX Announcement: This week, Imspex presents our doctoral student, Robin Curnow, co-sponsored by us and the University of Manchester. Robin shares insights into his impactful ...
Read More →
Featured

Meet Trenton Stewart

IMSPEX is proud to announce some of the current and upcoming projects led by one of our doctoral students, Trenton Stewart, co-sponsored by us and ...
Read More →
Events

BioWales in London

Tuesday 5th March, Canary Wharf, London IMSPEX is excited to share that our Group CEO, John McKinley, will be delivering a presentation at the MediWales ...
Read More →
Events

BioWales in London Pre-Event at The Shard

We’re pleased to announce that our Group CEO John McKinley will be participating in a panel discussion at Mathys & Squire IP Firm, located at The Shard ...
Read More →
Featured

IMSPEX Achieves New ISO Standard

We are pleased to announce that Imspex Diagnostic Ltd has achieved a significant milestone: the publication of a new ISO standard for Siloxane testing. Developed ...
Read More →
Featured

ONELAB Installation at the Amsterdam University Medical Center

Imspex is pleased to announce the successful installation of the Breathspec® instrument at Amsterdam University Medical Center. This achievement is part of the ONELAB project, ...
Read More →
Featured

ISO Certification

Imspex proudly announces its successful renewal of annual registration to ISO 13485:2016 for Medical Devices – Quality Systems – Requirements for Regulatory Purposes. This achievement ...
Read More →
Featured

ONELAB Annual Meeting

IMSPEX, as part of the ONELAB European Horizon project, attended the annual meeting held at Ghent University, Belgium, marking the first year completion of the ...
Read More →
Featured

ONELAB Installations

Imspex is pleased to announce the successful installation of the Breathspec® instrument at Saitama Medical Centre Hospital (SMCH), Saitama, Japan, an institution affiliated with the ...
Read More →
Events

Bevan Commission NHS 75 Conference

5th – 6th July 2023 Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting ...
Read More →
Events

LSX World Congress 2023

3rd – 4th May 2023 Our Group CEO John McKinley will be presenting in the MEDTECH Showcase on the 3rd May at 17:30 as part ...
Read More →
Events

AngloNordic Life Science Conference 2023

Our Group CEO John McKinley and PR, Social Media and Marketing Manager Amber Jacobs will be attending the 19th Annual AngloNordic Life Science Conference 2023 ...
Read More →
Events

MediWales Connects NHS Collaboration Conference 2023

29th June 2023 Our Group CEO John McKinley ,Technical Director Emma Brodrick and PR, Social Media and Marketing Manager Amber Jacobs ACIM will be in attendance hosting our exhibiting stand with ...
Read More →
Events

BioWales in London

Our Group CEO John McKinley will be presenting in the Company Showcase and participating in the Finance and Funding Panel at BioWales London on Tuesday 14th March ...
Read More →
Events

Arab Health 2023

Our Group CEO, John McKinley will be joining the Welsh Government and ABHI UK Pavilion at Arab Health 2023 in Dubai, UAE from Monday 30th ...
Read More →
Featured

Group B Streptococcus

Group B streptococcus (GBS) is a common bacterium found in the vagina of about 2 in 10 women in the UK. Being a carrier is ...
Read More →
Featured

Urine analysis for disease diagnostics or rapid screening

IMSPEX are working closely with partners to develop rapid screening tests using urine analysis. Direct headspace of urine allows rapid analysis of the volatile organic ...
Read More →
Featured

TOXI- Triage

In October 2018, Imspex/GAS were in Athens, involved in a full-scale field trial of ground breaking new technologies designed to improve the way the emergency ...
Read More →
Featured

TOXI – Triage – DISPERSE exercise

On 22nd May in Mikkeli, Finland, Imspex/GAS took part in the second TOXI- triage field exercise, DISPERSE. DISPERSE scenario simulated a chemical incident in a ...
Read More →
Featured

Leicester publication highlights Imspex and GC-IMS

Discriminatory Ability of Gas Chromatography–Ion Mobility Spectrometry to Identify Patients Hospitalized With COVID-19 and Predict Prognosis….. ‘GC-IMS shows promise as both a diagnostic tool and ...
Read More →
Events

MediWales Innovation Awards 2022

Our Imspex team look forward to attending this year’s MediWales Innovation Awards at the Mercure Cardiff Holland House on Thursday 8th December. Further information about ...
Read More →
Featured

ONELAB

Imspex are proud to be a part of the EU-funded ONELAB project. ONELAB focuses on designing and coordinating mobile laboratory operations for the detection and ...
Read More →
Featured

Everyday household items that contain VOCs

VOCs are compounds that easily become gases or vapours and are made up of lots of different elements where one of the elements is carbon.
Read More →
Featured

GC-IMS highlights Imspex as Benchmark Technology in VOC Gas

We are very proud to have been highlighted by the ISO committe as the benchmark in VOC Gas technology.
Read More →
Featured

Bond Digital Health Partners with Imspex Group

Bond Digital Health and Imspex Diagnostics will be working together on an exciting new technology.
Read More →
Featured

What’s your FlavourSpec this Oktoberfest?

For brewers, having access to an instrument such as FlavourSpec could be business transformational.
Read More →
Featured

Co-Vid 19 Resilience Innovation success

Imspex Diagnostics was successful in its recent SMARTCymru application for funding to further establish its BreathSpec® technology’s potential as a channel to boost economic recovery ...
Read More →
Featured

Low level detection of sulphur compounds in natural gas using the Agilent Micro GC with Ion Mobility Spectrometer

Low level detection of Sulphur compounds in Natural gas using the Agilent Micro GC with Ion Mobility Spectrometer. G.A.S mbH re-engineered its sophisticated Ion Mobility ...
Read More →
Featured

BBC exposure for BreathSpec system

BreathSpec system and the BBC – How should we deal with a chemical attack? The BreathSpec system has been gaining much publicity recently. Read about ...
Read More →
Featured

Monitoring of Toxic Industrial Chemicals (TICs)

Rapid Monitoring of Dimethyl Sulfate (DMS) in Chemical Plants using GC-IMS Technology Toxic industrial chemicals (TICs) or materials (TIMs) are substances that exhibit harmful effects ...
Read More →
Featured

Siloxanes in biogas gas from landfill waste

The generation of electricity from land fill is of increasing interest as a form of renewable energy to be used on site or sold to ...
Read More →
Featured

Authenticity of extra virgin olive oil

Want to know about how authentic extra virgin olive oil is? Keep reading… Extra virgin olive oil has always been a popular oil used in ...
Read More →

ECCMID 2023

Our Group CEO John McKinley will be attending the ECCMID 2023 in Copenhagen, Denmark on Monday 17th April. We look forward to seeing you there!

Read More »

BioWales in London

Our Group CEO John McKinley will be presenting in the Company Showcase and participating in the Finance and Funding Panel at BioWales London on Tuesday 14th March

Read More »